Product Program year 2025 Source: CMS Open Payments

Venxxiva

Drug Nephrology

Open in the dashboard

General payments

$12,356

515 payments

Research payments

$0

0 payments

Through program year 2025, $12,356 in general payments and $0 in research payments were reported against Venxxiva (Nephrology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $12,356 515

Breakdown

Who paid General payments · program year 2025
  1. Cycle Pharmaceuticals Inc $12,356 515 payments
Top recipients General payments · program year 2025
  1. Alexis Chesrow Urology · New Orleans, LA $122 <1% · 1 payment
  2. Lawrence Jenkins Urology · New Orleans, LA $122 <1% · 1 payment
  3. Jorge Caso Urology · New Orleans, LA $122 <1% · 1 payment
  4. Babak Azad Urology · Orange, CA $122 <1% · 1 payment
  5. Joanne Daniel Physician Assistant · Charlotte, NC $117 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $5,987 49% · 200 practitioners
  2. Nephrology Internal Medicine $2,919 24% · 103 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $999 8% · 38 practitioners
  4. Physician Assistant $837 7% · 29 practitioners
  5. Nurse Practitioner $353 3% · 14 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $1,451 12% · 42 recipients
  2. California $1,204 10% · 26 recipients
  3. Florida $1,176 10% · 57 recipients
  4. Texas $807 7% · 30 recipients
  5. Ohio $618 5% · 21 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

515 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record